Neuroone Medical Technologies is trading at $1.51 (-6.21%), with the decline appearing mainly linked to risk-off sentiment after Middle East tensions, higher oil prices, rising yields, and weaker technology-heavy indexes.
- No major company-specific announcement for September 2, 2026 was identified in available overnight coverage.
- Recent fiscal third-quarter results and product updates were reported on August 13, 2026, not overnight.
- Pre-market volume and activity levels were unavailable.